SACCOMANO NICHOLAS A (President and CEO) sold 19.2% of their position (874.00 shares) of ONKURE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/8/2025ACC: 0001415889-25-010419
DirectorOfficer· President and CEO
Since Oct 2024
-874.00
Net shares
Net seller
$2.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
874.00 disposed
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
−358.00
Price / share
$3.33
Trade value
$1.19K
% of position
7.9%
4/4/2025
4.56K→4.20K
Class A Common Stock
Direct
Shares
−516.00
Price / share
$2.67
Trade value
$1.38K
% of position
12.3%
4/7/2025
4.20K→3.68K
Total
Net shares
−874.00
Net value
-$2.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/4/2025 | S · Sale | −358.00 | $3.33 | $1.19K | 7.9% | 4.56K | 4.20K |
| Class A Common Stock Direct | 4/7/2025 | S · Sale | −516.00 | $2.67 | $1.38K | 12.3% | 4.20K | 3.68K |
| Total | −874.00 | -$2.57K | ||||||
Derivative Transactions0
No derivative transactions reported